NovaBay Pharmaceuticals Provides Business Update and 2013 Outlook

[at noodls] – Recent $7 Million Financing to Accelerate and Expand Clinical Trials Steady Progress Across Four Business Units: Ophthalmology • Viral conjunctivitis (unmet medical need) – Financing to accelerate Phase … more

View todays social media effects on NBY

View the latest stocks trending across Twitter. Click to view dashboard

See who NovaBay is hiring next, click here to view